Morning trading March 31, page-6

PAB announcement ,, this is huge and just the start of many more to come , multi multi bagger

Further United States patent granted for Patrys’ deoxymab assets

• A patent covering the use of Patrys’ novel deoxymabs (including both PAT-DX1 and PAT-DX3) in
combination with radiosensitising agent(s) that damage DNA or inhibit DNA repair, such as
cisplatin and doxorubicin, has been granted in the United States.
• This new patent further expands Patrys’ patent estate which covers a range of different ways to
use Patrys’ novel deoxymabs in their unconjugated form for the treatment of multiple types of
cancer.
• Several patents covering other applications for Patrys’ deoxymabs have already been granted in
key markets including the US, Europe, China and Japan.
Melbourne, Australia; 31 March 2021: Patrys Limited (ASX: PAB, “Patrys” or the “Company”), a
therapeutic antibody development company, is pleased to announce that US patent number:
10,961,301, titled “Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair” has been
granted. This new patent provides protection until August 2033.